Health care reform

Manatt Adds Renowned Provider Executive to National Health Care Industry Group

Retrieved on: 
Tuesday, February 20, 2024

Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today that Managing Director Mark Wietecha has joined the Firm’s national Health Care industry group in Washington, D.C.

Key Points: 
  • Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today that Managing Director Mark Wietecha has joined the Firm’s national Health Care industry group in Washington, D.C.
  • Additionally, Wietecha has a career interest in and deep global knowledge of children’s hospitals from both a policy and delivery systems perspective.
  • “In addition to his leadership with CHA, Mark has worked with hundreds of hospitals to understand the opportunities and challenges associated with their missions to increase access to and improve the delivery of care for children,” said Manatt Health Leader Bill Bernstein .
  • Prior to joining CHA, Wietecha served as a senior partner and executive chairman of a global consulting firm and founded its academic medical center consultancy within the firm’s health care sector.

Americans for Prosperity Launches New Ad Campaign in Support of the ACCESS Act

Retrieved on: 
Thursday, February 1, 2024

ARLINGTON, Va., Feb. 1, 2024 /PRNewswire/ -- Today, Americans for Prosperity launched a digital ad campaign to promote H.R. 5608, The ACCESS Act. This innovative legislation led by U.S. Reps. Greg Steube (FL-17) and Kat Cammack (FL-3) would allow lower-income Americans on ACA plans to put a portion of their CSR subsidies into a health savings account. This increases access to affordable health care and empowers individuals with more options to choose from.

Key Points: 
  • ARLINGTON, Va., Feb. 1, 2024 /PRNewswire/ -- Today, Americans for Prosperity launched a digital ad campaign to promote H.R.
  • This increases access to affordable health care and empowers individuals with more options to choose from.
  • The ACCESS Act would establish a tax-free health savings account (HSA) option for about 5 million lower-income families eligible for CSRs under the Affordable Care Act.
  • Click here to learn more about The ACCESS Act , health savings accounts , and AFP's vision for health care reform, the Personal Option .

HACU Announces Eleven Honorees to be Recognized at 37th Annual Conference on Hispanic Higher Education, Oct. 28-30, 2023

Retrieved on: 
Friday, October 20, 2023

The awards will be presented during HACU’s 37th Annual Conference, “Championing Hispanic Higher Education Success: Diversifying Our Workforce and Strengthening America,” taking place October 28 – 30, 2023, in Chicago, Illinois.

Key Points: 
  • The awards will be presented during HACU’s 37th Annual Conference, “Championing Hispanic Higher Education Success: Diversifying Our Workforce and Strengthening America,” taking place October 28 – 30, 2023, in Chicago, Illinois.
  • As the nation’s leading voice for Hispanic higher education and Hispanic-Serving Institutions, HACU has been a leader in securing the support of federal, corporate and higher education communities for programs and initiatives advancing Hispanic higher education.
  • “HACU is fortunate to have many great supporters who fulfill our mission of advancing Hispanic student success, and our awards recognize their efforts,” said HACU President and CEO Antonio R. Flores.
  • Michael Olivas, J.D., Ph.D., recipient of HACU’s Lifelong Leadership Award (posthumous award) for lifelong service to Hispanic higher education.

Iyah Romm, Founding CEO of Cityblock Health, Joins Board of Directors of Health-Tech Company Real

Retrieved on: 
Thursday, June 22, 2023

Real , the health-tech company reimagining mental health care, announced today that Iyah Romm has joined its Board of Directors.

Key Points: 
  • Real , the health-tech company reimagining mental health care, announced today that Iyah Romm has joined its Board of Directors.
  • Romm was the founding CEO and is currently a member of the Board of Directors of Cityblock Health, a tech-enabled health services company focused on scalable solutions for marginalized and underserved communities.
  • He ran the Company as CEO for five years, building a category-defining business that is reshaping the way health care is delivered to underserved communities.
  • As a member of Real’s Board of Directors, Romm brings his deep experience in startups and passion to democratize access to high quality, person-centered health care.

Aledade Welcomes Ananya Banerjee as Chief Commercial Officer

Retrieved on: 
Tuesday, December 20, 2022

- December 20, 2022 - Aledade announced that the company has expanded its senior leadership team, adding Ananya Banerjee as Chief Commercial Officer.

Key Points: 
  • - December 20, 2022 - Aledade announced that the company has expanded its senior leadership team, adding Ananya Banerjee as Chief Commercial Officer.
  • Prior to joining Aledade, Ananya served as Chief of Strategic Payer Partnerships at a leading senior care company.
  • "Ananya is uniquely qualified to take Aledade to the next level," says Farzad Mostashari, CEO and co-founder of Aledade.
  • Aledade recently announced Ritwik Tewari as its Chief Technology Officer and Phuong Phillips as its Chief Legal Officer.

Soligenix Announces Distribution of Series D Preferred Stock to Holders of its Common Stock

Retrieved on: 
Friday, December 23, 2022

The shares of Series D Preferred Stock will be distributed to such recipients at 5:00 p.m. Eastern Standard Time on January 4, 2023.

Key Points: 
  • The shares of Series D Preferred Stock will be distributed to such recipients at 5:00 p.m. Eastern Standard Time on January 4, 2023.
  • Subject to certain limitations, each outstanding share of Series D Preferred Stock will have 1,000,000 votes per share (or 1,000 votes per one one-thousandth of a share of Series D Preferred Stock).
  • The Series D Preferred Stock will be uncertificated, and no shares of Series D Preferred Stock will be transferable by any holder thereof except in connection with a transfer by such holder of any shares of the Company's common stock held by such holder.
  • In that case, a number of one one-thousandths of a share of Series D Preferred Stock equal to the number of shares of the Company's common stock to be transferred by such holder would be transferred to the transferee of such shares of common stock.

Jody Hoyos named Chief Executive Officer of the Prevent Cancer Foundation as Carolyn “Bo” Aldigé transitions into Founder role; new board members announced

Retrieved on: 
Monday, December 5, 2022

Alexandria, Va., Dec. 05, 2022 (GLOBE NEWSWIRE) -- The Prevent Cancer Foundation® today announces Jody Hoyos has been named Chief Executive Officer as Carolyn “Bo” Aldigé transitions into a Founder role.

Key Points: 
  • Alexandria, Va., Dec. 05, 2022 (GLOBE NEWSWIRE) -- The Prevent Cancer Foundation® today announces Jody Hoyos has been named Chief Executive Officer as Carolyn “Bo” Aldigé transitions into a Founder role.
  • Ms. Hoyos has been with the organization since December 2018 and has served as President and Chief Operating Officer of the Prevent Cancer Foundation since March 2021.
  • She cites this experience as her inspiration for starting the Prevent Cancer Foundation and leading the organization for 37 years.
  • For the past four years, she has worked with Ms. Hoyos to provide new direction and vision for the Foundation.

Orum Therapeutics Presents Positive Preclinical Data of ORM-6151, a First-in-Class, CD33-GSPT1 Dual-Precision Targeted Protein Degrader for AML, at ASH 2022

Retrieved on: 
Saturday, December 10, 2022

These data demonstrate we can increase the therapeutic index to improve the efficacy and tolerability of targeted protein degrader therapies with our TPD-squared approach, said Peter U.

Key Points: 
  • These data demonstrate we can increase the therapeutic index to improve the efficacy and tolerability of targeted protein degrader therapies with our TPD-squared approach, said Peter U.
  • Orum Therapeutics is a private, clinical-stage biotech pioneering the development of tumor-directed targeted protein degraders by leveraging its TPD approach to provide antibody-enabled cell-specific delivery.
  • This press release contains forward-looking statements that are based on the current expectations and beliefs of Orum Therapeutics, Inc. (Orum).
  • Orum cautions investors not to place considerable reliance on the forward-looking statements contained in this release.

Diabetes Leadership Council Names Congresswoman Diana DeGette, Senator Susan Collins and Senator Jeanne Shaheen as 2022 Diabetes Champions

Retrieved on: 
Tuesday, November 15, 2022

WASHINGTON, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The Diabetes Leadership Council (DLC) , a diabetes and health care reform advocacy organization advancing patient-centered policies at the local, state and federal levels, today announced Congresswoman Diana DeGette, Senator Susan Collins and Senator Jeanne Shaheen as its 2022 Diabetes Champions.

Key Points: 
  • WASHINGTON, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The Diabetes Leadership Council (DLC) , a diabetes and health care reform advocacy organization advancing patient-centered policies at the local, state and federal levels, today announced Congresswoman Diana DeGette, Senator Susan Collins and Senator Jeanne Shaheen as its 2022 Diabetes Champions.
  • Through their leadership of the Diabetes Caucus and Congressional efforts to reduce insulin costs, Congresswoman DeGette, Senators Collins and Shaheen truly demonstrate a commitment to the 37 million Americans living with diabetes, said Stewart Perry, Board Chair, Diabetes Leadership Council.
  • The Diabetes Leadership Council is a powerful and effective voice for diabetes patients.
  • Im honored to be named as one of the Diabetes Leadership Councils 2022 Diabetes Champions.

eHealth, Inc. Appoints John Stelben as Chief Financial Officer

Retrieved on: 
Monday, November 14, 2022

SANTA CLARA, Calif., Nov. 14, 2022 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced that it has appointed John Stelben as Chief Financial Officer, effective immediately. Stelben succeeds Christine Janofsky, who is leaving her role at eHealth.

Key Points: 
  • Brings More Than 25 Years of Financial and Operational Experience to CFO Role; Succeeds Christine Janofsky
    SANTA CLARA, Calif., Nov. 14, 2022 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced that it has appointed John Stelben as Chief Financial Officer, effective immediately.
  • Stelben brings more than 25 years of health insurance experience to eHealth.
  • Prior to that, Mr. Stelben had multiple senior financial roles at Coventry Health Care, Inc., including interim CFO as well as operational responsibilities for Medicare Advantage.
  • "I have worked closely with John for many years and have a deep appreciation of his significant financial leadership experience in healthcare.